✦ LIBER ✦

Biweekly cetuximab and irinotecan as second-line therapy in patients with gastro-esophageal cancer previously treated with platinum

✍ Scribed by Katrine R. Schoennemann; Jon K. Bjerregaard; Tine P. Hansen; Karin De Stricker; Morten F. Gjerstorff; Helle A. Jensen; Lene W. Vestermark; Per Pfeiffer

Book ID: 106281213
Publisher: Springer
Year: 2011
Tongue: English
Weight: 200 KB
Volume: 14
Category: Article
ISSN: 1436-3291
DOI: 10.1007/s10120-011-0031-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Second platinum therapy in patients with

Second platinum therapy in patients with uterine cervical cancer previously treated with platinum chemotherapy

✍ Maki Tanioka; Noriyuki Katsumata; Kan Yonemori; Tsutomu Kouno; Chikako Shimizu; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 173 KB

Successful and Well-Tolerated Second Lin

Successful and Well-Tolerated Second Line Therapy with Cetuximab, Irinotecan, and Raltitrexed in Progressive Liver Disease Due to Metastatic Colon Cancer

✍ F. Geurs; S. Vandewaeter; S. Ponette; J. Ponette; S. Knape; P. Demetter 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 161 KB

Retrospective analysis of 27 consecutive

Retrospective analysis of 27 consecutive patients treated with docetaxel/nedaplatin combination therapy as a second-line regimen for advanced esophageal cancer

✍ Masashi Kanai; Shigemi Matsumoto; Takahumi Nishimura; Yutaka Shimada; Go Watanab 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 214 KB

Phase II study of oral vinorelbine in co

Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes

✍ Alison Jones; Mary O’Brien; Harald Sommer; Elzbieta Nowara; Anja Welt; Tadeusz P 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 364 KB

High-dose 5-fluorouracil and leucovorin

High-dose 5-fluorouracil and leucovorin as second-line chemotherapy in patients with platinum-resistant epithelial ovarian cancer

✍ J. T. Kamphuis; M. C. Huider; G. J. Ras; C. A. H. Verhagen; I. Kateman; J. H. A. 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 265 KB

Second-line chemotherapy with fluorourac

Second-line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first-line platinum-based chemotherapy : A multicenter AGEO study

✍ Aziz Zaanan; Mélanie Gauthier; David Malka; Christophe Locher; Jean-Marc Gornet; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 1 views

## Abstract ## BACKGROUND: Small bowel adenocarcinoma (SBA) is a rare tumor with poor prognosis. First‐line platinum‐based chemotherapy is active in patients with advanced SBA, but data regarding second‐line chemotherapy are lacking. The aim of this study was to evaluate the efficacy and tolerabil